from pg 13 AR
"In June 2021, NEXTSTELLIS was launched into the US market and
is being supported by a highly experienced national women’s
health sales team. By August 2021, the sales team had held 20,000
in-person interactions with prescribers and reached more than
60% of priority prescriber targets."
Suggests there are about 33k priority prescribers in the US. The message is getting out - these docs have better things to do than talk about something of little interest. Assuming Mayne are not counting hang ups and line clicks - lol!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
0.000(0.00%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.25 | $5.30 | $5.18 | $1.126M | 214.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9347 | $5.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.28 | 2000 | 2 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |